CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- 4 Option exercise Chief Accounting Officer acquired 21,030 shares (option exercise)
- 10-Q Report Quarterly Report
- DEF 14C Other DEF 14C
- D Other Notice of Sales of Unregistered Securities
- SC 13D/A Stake Beneficial Ownership Report
- PRE 14C Other PRE 14C
- 4 Other acquisition See remarks acquired 209,291,936 shares (other)
- 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Other events
- 4 Option exercise Chief Financial Officer acquired 70,744 shares (option exercise)
- 4 Option exercise Chief Accounting Officer acquired 32,872 shares (option exercise)
- 4 Option exercise Director acquired 57,199 shares (option exercise)
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Material agreement
Page 9 of 28 · 557 filings